Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.
about
Phosphodiesterases as therapeutic targets for Alzheimer's disease.NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade.Alzheimer's disease and age-related memory decline (preclinical)Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice.Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques.Neurorestorative treatment of stroke: cell and pharmacological approaches.PDE5 inhibitors beyond erectile dysfunction.PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic DiseaseStriatal lesions interfere with acquisition of a complex maze task in ratsSelective phosphodiesterase inhibitors: a promising target for cognition enhancement.A placebo-controlled study of sildenafil effects on cognition in schizophrenia.Role of phosphodiesterase 5 in synaptic plasticity and memoryInvolvement of nitric oxide in learning & memory processes.Regulation of injury-induced neurogenesis by nitric oxide.Selective inhibition of phosphodiesterase 5 enhances glutamatergic synaptic plasticity and memory in mice.The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome.The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans.Classical eyeblink conditioning during acute hypobaric hypoxia is improved in acclimatized mice and involves Fos expression in selected brain areas.The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice.Use of behavioural and long-term potentiation models in the development of memory-improving drugs.
P2860
Q28279704-1FA39D37-1946-4EC2-A75A-3FF40F9395F5Q33496256-DB6C3338-6F1E-410E-A443-CC9D6798FC58Q35041190-3005641B-4A35-4557-9968-171EE1C450DAQ35635988-3CD41C4B-C3AA-4AA3-9439-6C1A6828E0EAQ36106513-32B42DBE-D015-409B-8223-E9966BB58560Q36462838-3FE15854-666A-4B16-8EE0-B4317A1283F9Q36608810-2E3A3508-3EEE-48CE-A979-9DDCB95970D0Q36878017-D6F8A16C-7B9E-4219-9ADF-C53ABE0663BDQ37053929-17914BBC-B65D-48D7-9186-2752837130CCQ37073858-F6925943-CF0B-4CB3-8F48-88FD57ED30CFQ37245947-3D6428FE-287A-4717-9C0A-442B02B0E824Q37247557-7B53526C-2622-4D0F-920A-DA3CFD66F41AQ37252748-5C3E2C7B-ED2F-4038-A69A-53894C5F4C4CQ37881831-290108C7-25BF-44F9-ACF1-765D494EE560Q42041084-37E2BB6B-75C5-453D-A751-926E1588CE27Q42437731-0E33F789-10E8-428A-869B-7BEAC902AC08Q43338890-D60A22EE-0EB4-42C0-9509-09A89581CE25Q44240737-21FCD991-1457-4576-9CDF-C12B5A390FC0Q48100200-E1FAA8A8-8B40-4CC5-B7C9-D9E5CD90B297Q48161288-362FD5F0-7318-4F8C-9D99-838CF326DCB9Q51962312-D6E72431-1831-4B64-8012-86BBB7AAAEE7
P2860
Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Phosphodiesterase inhibition b ...... ric oxide synthase inhibition.
@en
Phosphodiesterase inhibition b ...... ric oxide synthase inhibition.
@nl
type
label
Phosphodiesterase inhibition b ...... ric oxide synthase inhibition.
@en
Phosphodiesterase inhibition b ...... ric oxide synthase inhibition.
@nl
prefLabel
Phosphodiesterase inhibition b ...... ric oxide synthase inhibition.
@en
Phosphodiesterase inhibition b ...... ric oxide synthase inhibition.
@nl
P2093
P2860
P1433
P1476
Phosphodiesterase inhibition b ...... ric oxide synthase inhibition.
@en
P2093
Bryan D Devan
Christopher M Nelson
Demetrio Sierra-Mercado
Donald K Ingram
Edward L Spangler
Ila S Bharati
Jonna L Bowker
Kara B Duffy
Mariana Jimenez
P2860
P2888
P304
P356
10.1007/S00213-005-0232-Z
P577
2005-11-18T00:00:00Z